Department of Advanced Medicine for Respiratory Failure, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Department of Respiratory Care and Sleep Control Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
J Clin Sleep Med. 2023 Aug 1;19(8):1557-1561. doi: 10.5664/jcsm.10564.
Servo-ventilation (SV) was developed for treating central sleep apnea. To date, primarily SV devices manufactured by Philips Respironics and ResMed are used. However, the difference in reaction to sleep-disordered breathing events between bilevel positive airway pressure AutoSV devices from Philips and adaptive SV devices from ResMed in clinical settings is unknown. Herein, we describe a case of central sleep apnea in which sleep-disordered breathing events were successfully controlled and sleepiness, sleep quality, and tolerance of the device were improved by changing from the bilevel positive airway pressure AutoSV device from Philips to the adaptive SV device from ResMed. Changing the SV devices can be a clinical option to appropriately control sleep-disordered breathing events in patients receiving SV therapy who present with persistent sleep-disordered breathing.
Hamada S, Togawa J, Sunadome H, Nagasaki T, Hirai T, Sato S. Good clinical response achieved by changing servo-ventilation devices in a patient with central sleep apnea: a case report. . 2023;19(8):1557-1561.
目的:SV 最初是为治疗中枢性睡眠呼吸暂停而开发的。目前,主要使用飞利浦伟康和瑞思迈生产的 SV 设备。然而,在临床环境中,飞利浦的双水平气道正压 AutoSV 设备和瑞思迈的自适应 SV 设备对睡眠呼吸紊乱事件的反应是否存在差异尚不清楚。本文介绍了 1 例中枢性睡眠呼吸暂停患者,该患者从飞利浦的双水平气道正压 AutoSV 设备更换为瑞思迈的自适应 SV 设备后,睡眠呼吸紊乱事件得到了成功控制,嗜睡、睡眠质量和对设备的耐受性均得到了改善。
结论:对于接受 SV 治疗且持续存在睡眠呼吸紊乱的患者,更换 SV 设备可能是一种控制睡眠呼吸紊乱事件的临床选择。